Cargando…
Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?
The majority of people infected with SARS-CoV-2 are asymptomatic or have mild to moderate symptoms. However, for unknown reasons, about 15 % have severe pneumonia requiring hospital care and oxygen support, and about 5 % develop acute respiratory distress syndrome, septic shock, and multiorgan failu...
Autor principal: | Söderberg-Nauclér, Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952506/ https://www.ncbi.nlm.nih.gov/pubmed/33712035 http://dx.doi.org/10.1186/s12979-021-00218-z |
Ejemplares similares
-
Autoimmunity induced by human cytomegalovirus in patients with systemic lupus erythematosus
por: Söderberg-Nauclér, Cecilia
Publicado: (2012) -
Cytomegalovirus infection in brain tumors: A potential new target for therapy?
por: Söderberg-Nauclér, Cecilia, et al.
Publicado: (2012) -
Is human cytomegalovirus a target in cancer therapy?
por: Johnsen, John Inge, et al.
Publicado: (2011) -
New mechanistic insights of the pathogenicity of high-risk cytomegalovirus (CMV) strains derived from breast cancer: Hope for new cancer therapy options
por: Söderberg-Nauclér, Cecilia
Publicado: (2022) -
Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?
por: Kalil, Andre C, et al.
Publicado: (2011)